Retatrutide （20mg）

Retatrutide is a novel, multi-receptor agonist peptide that simultaneously targets the GLP-1, GIP, and glucagon receptors. By activating these three pathways, Retatrutide offers enhanced effects on glucose control, appetite suppression, and energy expenditure. This multi-action mechanism leads to significant weight loss, improved insulin sensitivity, and better metabolic health outcomes compared to single-pathway peptides. Recent studies suggest that Retatrutide may also help reduce liver fat and improve cardiovascular markers in individuals with obesity or metabolic disorders.